semaglutide makes me gassy Ozempic: is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss GLP-1 Meds Slowed Your Digestion?

doi:10.3389/fendo.2018.00672 27

consult your pharmacist for advice If reflux symptoms are persistent or severe, your GP may prescribe a proton pump inhibitor (PPI) such as omeprazole or lansoprazole to reduce stomach acid production, in accordance with NICE guidance on GORD management

Key Tirzepatide Formulations Mounjaro: FDA-approved for type 2 diabetes management Zepbound: FDA-approved for chronic weight management in adults with BMI 30 or greater, or BMI 27 or greater with a weight-related comorbidity Efficacy Comparison The SURMOUNT-1 trial showed tirzepatide at 15 mg weekly produced average weight loss of 22.5% of body weight at 72 weeks, compared to approximately 15% to 17% with semaglutide 2.4 mg in the STEP trials

Why Choose a Medical Program Instead of Medication Alone

If you inject 1 mg of semaglutide today, one week from now approximately 0.5 mg remains in your system